25P Association between the lung immune prognostic index (LIPI) and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer (NSCLC)
Title:
25P Association between the lung immune prognostic index (LIPI) and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer (NSCLC)
Author:
Riudavets Melia, M. Auclin, E. Aboubakar, F. Ponce Aix, S. Dal Maso, A. Bluthgen, V. Mielgo, X. Mussat, E. Reyes, R. BenÃtez, J. Lupinacci, L. Duchemann, B. de Giglio, A. Bautista, J. Audigier-Valette, C. Scheffler, M. Campayo, M. Besse, B. Planchard, D. Mezquita, L.